Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $28.75B | $27.12B | +6.04% |
Cost of Revenue | $6.25B | $6.5B | -3.80% |
Operating Income | $1.66B | $7.61B | -78.15% |
Net Income | $480M | $5.67B | -91.53% |
EPS (Basic) | $0.38 | $4.54 | -91.63% |
EPS (Diluted) | $0.38 | $4.50 | -91.56% |
SG&A Expense | $6.09B | $6.09B | +0.02% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $58.99B | $62.13B | -5.04% |
Current Assets | $19.17B | $16.09B | +19.20% |
Current Liabilities | $12B | $11.28B | +6.42% |
Stockholders' Equity | $19.33B | $22.83B | -15.34% |
Long-Term Debt | $26.71B | $24.99B | +6.90% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $10.83B | $8.01B | +35.25% |
Investing Cash Flow | $-3.45B | $-2.27B | -52.27% |
Financing Cash Flow | $-3.43B | $-5.13B | +33.01% |
Dividends Paid | $3.92B | $3.81B | +2.86% |
Share Buybacks | $1.15B | $1B | +15.00% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 5.8% | 28.0% | -22.27% |
Net Margin | 1.7% | — | — |
ROE | 2.5% | — | — |
ROA | 0.8% | — | — |
Current Ratio | $1.597 | — | — |
Other companies in Biotechnology